(Q39656423)

13 September 2017

title

Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

Barbie Taylor-Harding

1

1 reference

13 September 2017

Sandra Orsulic

2

1 reference

13 September 2017

Beth Y. Karlan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837358

12 July 2024

Andrew J. Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837358

12 July 2024

language of work or name

English

0 references

publication date

15 September 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0090825810006116?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2010.08.017

https://api.elsevier.com/content/article/PII:S0090825810006116?httpAccept=text/plain

12 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2010.08.017

12 July 2024

1 reference

13 September 2017

volume

119

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

549-556

1 reference

13 September 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

The biology of ovarian cancer: new opportunities for translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statins prevent coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statin use and cancer risk in the General Practice Research Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statin use and female reproductive organ cancer risk in a large population-based setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Impact of statin therapy on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Ras-superfamily GTP-ases in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Membrane association and targeting of prenylated Ras-like GTPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Lovastatin-induced RhoA modulation and its effect on senescence in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Statins have biphasic effects on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Emerging role of RAB GTPases in cancer and human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

The emerging role of the RAB25 small GTPase in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Rab GTPases as coordinators of vesicle traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Breast cancer growth prevention by statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

Posttranslational modification of proteins by isoprenoids in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.08.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Synergistic interaction of lovastatin and paclitaxel in human cancer cells

19

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2010.08.017

Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase

12 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2010.08.017

12 July 2024

Identifiers

1 reference

13 September 2017

1 reference